Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1400 of 2529 entries
View as:

Efficacy and Safety Study of ACZ885 in Patients With Active Recurrent or Chronic TNF-receptor Associated Periodic Syndrome (TRAPS).

Phase: N/A Priority: Normal
NCT ID: NCT01242813 Org: User:
Start: 10/31/10 End: 06/30/14 Due: 06/30/15

PK and Safety of Midostaurin in Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT01429337 Org: User:
Start: 03/07/11 End: 05/09/20 Due: 05/09/21

A Post Marketing Surveillance on Piqray in Korea

Phase: N/A Priority: Normal
NCT ID: NCT05293470 Org: User:
Start: 06/29/22 End: 05/12/27 Due: 05/12/28

Study to Investigate the Efficacy and Safety of QGE031 in Adolescent Patients With Chronic Spontaneous Urticaria (CSU)

Phase: N/A Priority: Normal
NCT ID: NCT03437278 Org: User:
Start: 08/01/18 End: 02/03/21 Due: 02/03/22

Safety, Pharmacokinetics and Pharmacodynamics of TKI258 in Subjects With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00279773 Org: User:
Start: 09/30/04 End: - Due: -

LUTATHERA Injection General Use Result Survey

Phase: N/A Priority: Normal
NCT ID: NCT05844332 Org: User:
Start: 12/17/21 End: 06/27/24 Due: 06/27/25

Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT05350072 Org: User:
Start: 07/28/22 End: 05/06/27 Due: 05/06/28

A Multi-center, Ambispective Cohort Study to Evaluate the Impact of Iptacopan for Adult Patients With PNH in China

Phase: N/A Priority: Normal
NCT ID: NCT06931691 Org: User:
Start: 06/10/25 End: 04/20/27 Due: 04/20/28

An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Participants With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Blast Crisis

Phase: N/A Priority: Normal
NCT ID: NCT00171158 Org: User:
Start: 07/26/99 End: 04/22/13 Due: 04/22/14

Efficacy and Safety of Patupilone in Patients With Advanced Solid Tumors in Japan

Phase: N/A Priority: Normal
NCT ID: NCT00412789 Org: User:
Start: 08/31/06 End: - Due: -

Safety, Tolerability, and Pharmacokinetics of Iloperidone Depot in Schizophrenic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01348100 Org: User:
Start: 04/30/11 End: 07/31/12 Due: 07/31/13

This Was a Dose-finding Study to Evaluate Efficacy and Safety of LOU064 in Patients With CSU Inadequately Controlled by H1-antihistamines

Phase: N/A Priority: Normal
NCT ID: NCT03926611 Org: User:
Start: 06/06/19 End: 04/15/21 Due: 04/15/22

Compare the Effect of Aliskiren Plus Valsartan Versus Angiotensin-Converting Enzyme Inhibitor (ACEi) Plus Angiotensin Receptor Blocker (ARB) [Ramipril Plus Telmisartan] on the Renin-Angiotensin-Aldosterone System (RAAS) in Hypertensive Patients

Phase: N/A Priority: Normal
NCT ID: NCT00939588 Org: User:
Start: 07/31/09 End: - Due: -

Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients

Phase: N/A Priority: Normal
NCT ID: NCT01769768 Org: User:
Start: 04/30/13 End: 08/31/16 Due: 08/31/17

Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00154375 Org: User:
Start: 10/31/04 End: - Due: -

Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by Inflammation

Phase: N/A Priority: Normal
NCT ID: NCT03373461 Org: User:
Start: 02/07/18 End: 06/22/21 Due: 06/22/22

Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin

Phase: N/A Priority: Normal
NCT ID: NCT00958841 Org: User:
Start: 09/30/09 End: 06/30/15 Due: 06/30/16

Patients With Relapse Remitting Multiple Sclerosis (RRMS): Candidates for MS Therapy Change

Phase: N/A Priority: Normal
NCT ID: NCT01317004 Org: User:
Start: 05/31/11 End: 06/30/14 Due: 06/30/15

Study of Efficacy and Safety of Ofatumumab in Relapsing Multiple Sclerosis (RMS) Patients in China

Phase: N/A Priority: Normal
NCT ID: NCT05199571 Org: User:
Start: 07/22/22 End: 02/13/25 Due: 02/13/26

Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy

Phase: N/A Priority: Normal
NCT ID: NCT05722522 Org: User:
Start: 08/10/23 End: 12/13/24 Due: 12/13/25

A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via TWISTHALER® Device in Adult and Adolescent Patients With Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00545272 Org: User:
Start: 10/31/07 End: 04/30/08 Due: 04/30/09

Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients

Phase: N/A Priority: Normal
NCT ID: NCT03656562 Org: User:
Start: 12/19/18 End: 04/24/26 Due: 04/24/27

A 24-week rPMS Study in Real-world Setting for Enerzair

Phase: N/A Priority: Normal
NCT ID: NCT05274425 Org: User:
Start: 05/09/22 End: 03/11/27 Due: 03/11/28

A Study of Dabrafenib in Combination With Trametinib in Chinese Patients With BRAF V600E Mutant Metastatic NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT04452877 Org: User:
Start: 08/19/20 End: 11/07/24 Due: 11/07/25

Dose Escalation Study of LGH447 in Japanese Patients With Relapsed and/or Refractory Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT02160951 Org: User:
Start: 09/30/14 End: 05/31/16 Due: 05/31/17